文献速递免疫规划慢病防控与筛查

评估真实世界疫苗效果:苏格兰监测人乳头瘤病毒(HPV)疫苗对HPV感染和宫颈疾病影响的路径综述

Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease.
PubMed 文献 · Vaccine · 2024-08-10

苏格兰于2008年启动HPV疫苗接种规划,目标人群为12-13岁女孩,前三年对18岁以下女孩补种,后扩展至男孩及男男性行为者。通过链接国家免疫与筛查数据库,可直接监测疫苗对病毒学和病理学结局的影响,分析显示疫苗对HPV感染、宫颈疾病和宫颈癌具有高效力,并在未接种女性中观察到群体免疫。持续监测对评估保护时长、疫苗与剂次方案变化及型别替换至关重要。

要点

  • 苏格兰HPV疫苗规划2008年启动,目标12-13岁女孩,前三年补种至18岁,后扩展至男孩及男男性行为者。
  • 链接国家免疫与筛查数据库可直接监测HPV疫苗对病毒学和病理学结局的影响。
  • 分析显示疫苗对HPV感染、宫颈疾病和宫颈癌有高效力,未接种女性中观察到群体免疫。

核心结论

  • 链接数据提供真实世界证据表明HPV疫苗对HPV感染、宫颈疾病和宫颈癌具有高效力,未接种女性中观察到群体免疫。
  • 持续监测对评估保护时长、疫苗与剂次方案变化的影响及潜在型别替换的出现至关重要。
  • 实现WHO消除宫颈癌目标需针对宫颈癌风险最高的女性采取靶向干预,以确保苏格兰所有女性及时受益。

研究设计与样本

  • 本文为对苏格兰HPV疫苗影响监测路径的综述,描述2008年启动的HPV疫苗接种规划及其演变,以及通过链接国家免疫与筛查数据库直接监测疫苗对病毒学和病理学结局影响的方法。

主要发现

  • 苏格兰HPV疫苗接种规划于2008年启动,目标12-13岁女孩,前三年补种至18岁女孩,后疫苗类型、剂次方案变化并扩展至男孩及男男性行为者。
  • 苏格兰疫苗 uptake 历史上较高但随时间逐渐下降,且来自较贫困地区的女性存在差异。
  • 链接数据分析显示真实世界证据表明疫苗对HPV感染、宫颈疾病和宫颈癌具有高效力,未接种女性中观察到群体免疫。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-risk human papillomavirus (HPV) infections can progress to cervical cancer which is the fourth most common cancer in women globally. In Scotland, the incidence of cervical cancer has a strong socioeconomic deprivation gradient disproportionately affecting women from more deprived areas. An HPV vaccination programme was initiated in Scotland in 2008 targeting girls aged 12-13 years with a catch-up campaign running for the first three years for girls aged up to 18 years. The programme has evolved over the last 16 years with changes in the type of vaccine, dosing schedules and the extension of the programme to boys and gay, bisexual and other men who have sex with men. Vaccine uptake in Scotland has historically been high but has gradually decreased over time and disparities exist in women from more deprived areas of Scotland. The ability to link national immunisation and screening databases in Scotland has allowed direct monitoring of the impact of the HPV vaccine on virological and histological outcomes. Analyses of this linked data have demonstrated real-world evidence of high vaccine effectiveness against HPV infection, cervical disease, and cervical cancer with evidence of herd immunity in unvaccinated women. Continued monitoring is crucial to assess the duration of protection, the impact of vaccine and dosing schedules changes and the emergence of potential type replacement. With the World Health Organisation's aim to eliminate cervical cancer as a public health problem by the next century addressing the inequalities in cervical cancer incidence will be crucial. This will require targeted interventions for women most at risk of cervical cancer to ensure elimination is achieved timely for all women in Scotland.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Cameron RL, Palmer TJ, Cuschieri K, et al. Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease. Vaccine. 2024. PMID: 39128198. doi:10.1016/j.vaccine.2024.126177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。